Cardiovascular outcome in systemic sclerosis

被引:0
|
作者
Voilliot, Damien [1 ,2 ]
Magne, Julien [1 ,2 ]
Dulgheru, Raluca [1 ,2 ]
Kou, Seisyou [1 ,2 ]
Henri, Christine [1 ,2 ]
Caballero, Luis [1 ,2 ]
De Sousa, Carla [1 ,2 ]
Sprynger, Muriel [1 ,2 ]
Andre, Beatrice [3 ]
Pierard, Luc A. [1 ,2 ]
Lancellotti, Patrizio [1 ,2 ]
机构
[1] Univ Liege Hosp, GIGA Cardiovasc Sci, Dept Cardiol, Heart Valve Clin,CHU Sart Tilman, Liege, Belgium
[2] ES Hlth Sci Fdn, GVM Care & Res, Lugo, RA, Spain
[3] Univ Hosp Sart Tilman, Dept Rheumatol, Univ Liege Hosp, Liege, Belgium
关键词
Systemic sclerosis; echocardiography; pulmonary hypertension; exercise; nailfold videocapillaroscopy; cardio-vascular diseases; brain natriuretic peptide; BRAIN NATRIURETIC PEPTIDE; PULMONARY ARTERIAL-HYPERTENSION; SEVERE ORGAN INVOLVEMENT; PREDICTION; CAPACITY; DISEASE;
D O I
10.1080/AC.70.5.3110516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Cardiovascular involvement is recognized as a poor prognostic factor in systemic sclerosis (SSc). The aim of this study was to evaluate the usefulness of nailfold video-capillaroscopy (NVC), brain natriuretic peptide (BNP) blood level and exercise echocardiography to predict the occurrence of cardiovascular events in SSc. Methods We prospectively enrolled 65 patients with SSc (age 54 +/- 14 years, 30% female) followed in CHU Sart-Tilman, Liege, Belgium. All patients underwent graded semi-supine exercise echocardiography. Both baseline resting pulmonary hypertension (PH) and PH during follow-up (FUPH) were defined as systolic pulmonary arterial pressure (sPAP) >35 mmHg, and exercise-induced PH (EIPH) as sPAP >50 mmHg during exercise. Results EIPH was present in 21 patients. During FU (27 +/- 18 months), 13 patients developed FUPH and 9 presented cardiovascular complications. Patients with cardiovascular events were significantly older (63 +/- 14 vs 52 +/- 13 years; P = 0.03), presented more frequently NVC grade >2 (89 vs 43%; P = 0.009), had higher resting and exercise sPAP (30 +/- 6 vs 24 +/- 6; P = 0.007 and 57 +/- 13 vs 44 +/- 13 vs mmHg; P = 0.01, respectively), and higher BNP blood level (112 +/- 106 vs 26 +/- 19 pg/ml; P = 0.0001). After adjustment for age and gender, NVC grade >2 (beta = 2.4 +/- 1.1; P = 0.03), EIPH (beta = 2.30 +/- 1.13; P = 0.04), FUPH (beta = 0.24 +/- 0.09; P = 0.01 and beta = 3.52 +/- 1.16; P = 0.002, respectively;) and BNP (beta = 0.08 +/- 0.04; P = 0.02) were independent predictors of CV events. Beyond age, an incremental value of EIPH, BNP and NVC grade >2 was predictive of cardiovascular events (P < 0.001). Conclusion Cardiovascular complications are not rare in SSc (18%). NVC, BNP blood level assessment and exercise echocardiography could be useful tools to identify patients at risk of SSc.
引用
下载
收藏
页码:554 / 563
页数:10
相关论文
共 50 条
  • [1] Cardiovascular outcome predictors in systemic sclerosis
    Voilliot, D. V.
    Magne, J. M.
    Dulgheru, R. D.
    Kou, S. K.
    Henri, C. H.
    Caballero, L. C.
    De Sousa, C. D. S.
    Sprynger, M. S.
    Pierard, L. P.
    Lancellotti, P. L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 247 - 247
  • [2] EVALUATION OF CARDIOVASCULAR DETERMINANTS OF DISEASE OUTCOME IN SYSTEMIC SCLEROSIS
    Kalaszi, Mariann
    Laczik, Renata
    Soltesz, Pal
    Hodosi, Katalin
    Szamosi, Szilvia
    Szekanecz, Zoltan
    Szucs, Gabriella
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1805 - 1805
  • [3] CORONARY ARTERY CALCIFCATION IN SYSTEMIC SCLEROSIS: EVALUATION OF CARDIOVASCULAR RISK AND CLINICAL OUTCOME
    Sciacca, S.
    Rotondo, C.
    Corrado, A.
    Cici, D.
    Cantatore, F. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 763 - 763
  • [4] Cardiovascular involvement in systemic sclerosis
    Constans, J
    Skopinski, S
    Barcat, D
    Conri, C
    ANNALES DE MEDECINE INTERNE, 2002, 153 (04): : 242 - 249
  • [5] Cardiovascular disease in systemic sclerosis
    Cannarile, Francesca
    Valentini, Valentina
    Mirabelli, Giulia
    Alunno, Alessia
    Terenzi, Riccardo
    Luccioli, Filippo
    Gerli, Roberto
    Bartoloni, Elena
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (01)
  • [6] Cardiovascular Risk in Systemic Sclerosis
    Eleni Angeloudi
    Eleni Pagkopoulou
    Alexandra Arvanitaki
    Stergios Soulaidopoulos
    Alexandros Garyfallos
    George Kitas
    Theodoros Dimitroulas
    Current Treatment Options in Rheumatology, 2020, 6 : 282 - 298
  • [7] Cardiovascular Risk in Systemic Sclerosis
    Angeloudi, Eleni
    Pagkopoulou, Eleni
    Arvanitaki, Alexandra
    Soulaidopoulos, Stergios
    Garyfallos, Alexandros
    Kitas, George
    Dimitroulas, Theodoros
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2020, 6 (03) : 282 - 298
  • [8] Cardiovascular risk and prostanoids in systemic sclerosis
    Colaci, M.
    Sebastiani, A.
    Giuggioli, D.
    Manfredi, A.
    Rossi, R.
    Modena, M. G.
    Ferri, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 333 - 336
  • [9] An Update of Outcome Measures in Systemic Sclerosis
    Chang, Ting Yi Jessica
    Pope, Janet E.
    ARTHRITIS CARE & RESEARCH, 2020, 72 : 110 - 133
  • [10] THE CARDIOVASCULAR MANIFESTATIONS OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
    FOLLANSBEE, WP
    CURRENT PROBLEMS IN CARDIOLOGY, 1986, 11 (05) : 245 - 290